153 related articles for article (PubMed ID: 21105677)
1. Removal of the 26-methyl group from 19-nor-1α,25-dihydroxyvitamin D₃ markedly reduces in vivo calcemic activity without altering in vitro VDR binding, HL-60 cell differentiation, and transcription.
Grzywacz P; Chiellini G; Plum LA; Clagett-Dame M; DeLuca HF
J Med Chem; 2010 Dec; 53(24):8642-9. PubMed ID: 21105677
[TBL] [Abstract][Full Text] [Related]
2. New 1alpha,25-dihydroxy-19-norvitamin D3 compounds of high biological activity: synthesis and biological evaluation of 2-hydroxymethyl, 2-methyl, and 2-methylene analogues.
Sicinski RR; Prahl JM; Smith CM; DeLuca HF
J Med Chem; 1998 Nov; 41(23):4662-74. PubMed ID: 9804706
[TBL] [Abstract][Full Text] [Related]
3. 26-Desmethyl-2-methylene-22-ene-19-nor-1α,25-dihydroxyvitamin D3 compounds selectively active on intestine.
Chiellini G; Grzywacz P; Plum LA; Clagett-Dame M; DeLuca HF
Steroids; 2014 May; 83():27-38. PubMed ID: 24513051
[TBL] [Abstract][Full Text] [Related]
4. 2-Ethyl and 2-ethylidene analogues of 1alpha,25-dihydroxy-19-norvitamin D(3): synthesis, conformational analysis, biological activities, and docking to the modeled rVDR ligand binding domain.
Sicinski RR; Rotkiewicz P; Kolinski A; Sicinska W; Prahl JM; Smith CM; DeLuca HF
J Med Chem; 2002 Aug; 45(16):3366-80. PubMed ID: 12139448
[TBL] [Abstract][Full Text] [Related]
5. 2-Methylene analogs of 1alpha-hydroxy-19-norvitamin D3: synthesis, biological activities and docking to the ligand binding domain of the rat vitamin D receptor.
Grzywacz P; Plum LA; Sicinska W; Sicinski RR; Prahl JM; DeLuca HF
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):13-7. PubMed ID: 15225739
[TBL] [Abstract][Full Text] [Related]
6. A Methylene Group on C-2 of 24,24-Difluoro-19-nor-1α,25-dihydroxyvitamin D3 Markedly Increases Bone Calcium Mobilization in Vivo.
Flores A; Massarelli I; Thoden JB; Plum LA; DeLuca HF
J Med Chem; 2015 Dec; 58(24):9731-41. PubMed ID: 26630444
[TBL] [Abstract][Full Text] [Related]
7. New 2-alkylidene 1alpha,25-dihydroxy-19-norvitamin D3 analogues of high intestinal activity: synthesis and biological evaluation of 2-(3'-alkoxypropylidene) and 2-(3'-hydroxypropylidene) derivatives.
Glebocka A; Sicinski RR; Plum LA; Clagett-Dame M; DeLuca HF
J Med Chem; 2006 May; 49(10):2909-20. PubMed ID: 16686534
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological activity of 2-(3'-hydroxypropylidene)-1α-hydroxy-19-norvitamin D analogues with shortened alkyl side chains.
Glebocka A; Sicinski RR; Plum LA; Deluca HF
J Med Chem; 2011 Oct; 54(19):6832-42. PubMed ID: 21902235
[TBL] [Abstract][Full Text] [Related]
9. 26- and 27-Methyl groups of 2-substituted, 19-nor-1α,25-dihydroxylated vitamin D compounds are essential for calcium mobilization in vivo.
Grzywacz P; Plum LA; Clagett-Dame M; DeLuca HF
Bioorg Chem; 2013 Apr; 47():9-16. PubMed ID: 23474215
[TBL] [Abstract][Full Text] [Related]
10. New highly calcemic 1 alpha,25-dihydroxy-19-norvitamin D(3) compounds with modified side chain: 26,27-dihomo- and 26,27-dimethylene analogs in 20S-series.
Sicinski RR; Prahl JM; Smith CM; DeLuca HF
Steroids; 2002 Mar; 67(3-4):247-56. PubMed ID: 11856548
[TBL] [Abstract][Full Text] [Related]
11. New derivative of 1alpha,25-dihydroxy-19-norvitamin D3 with 3'-alkoxypropylidene moiety at C-2: synthesis, biological activity and conformational analysis.
Glebocka A; Sicinski RR; DeLuca HF
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):25-30. PubMed ID: 15225741
[TBL] [Abstract][Full Text] [Related]
12. 2-(3'-Hydroxypropylidene)-1alpha-hydroxy-19-norvitamin D compounds with truncated side chains.
Glebocka A; Sicinski RR; Plum LA; DeLuca HF
J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):310-5. PubMed ID: 17223340
[TBL] [Abstract][Full Text] [Related]
13. Novel ring A stereoisomers of 2-methyl-1alpha,25-dihydroxyvitamin D(3) and 2-methyl-20-epi-1alpha,25-dihydroxyvitamin D(3): transactivation of target genes and modulation of differentiation in human promyelocytic leukemia (HL-60) cells.
Nakagawa K; Kurobe M; Ozono K; Konno K; Fujishima T; Takayama H; Okano T
Biochem Pharmacol; 2000 Mar; 59(6):691-702. PubMed ID: 10677586
[TBL] [Abstract][Full Text] [Related]
14. 13,13-Dimethyl-des-C,D analogues of (20S)-1α,25-dihydroxy-2-methylene-19-norvitamin D₃ (2MD): total synthesis, docking to the VDR, and biological evaluation.
Plonska-Ocypa K; Sibilska I; Sicinski RR; Sicinska W; Plum LA; DeLuca HF
Bioorg Med Chem; 2011 Dec; 19(23):7205-20. PubMed ID: 22018918
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological activity of 22-iodo- and (E)-20(22)-dehydro analogues of 1alpha,25-dihydroxyvitamin D3.
Sicinski RR; DeLuca HF
Bioorg Med Chem; 1999 Dec; 7(12):2877-89. PubMed ID: 10658592
[TBL] [Abstract][Full Text] [Related]
16. 13-Methyl-substituted des-C,D analogs of (20S)-1alpha,25-dihydroxy-2-methylene-19-norvitamin D3 (2MD): synthesis and biological evaluation.
Plonska-Ocypa K; Sicinski RR; Plum LA; Grzywacz P; Frelek J; Clagett-Dame M; DeLuca HF
Bioorg Med Chem; 2009 Feb; 17(4):1747-63. PubMed ID: 19167893
[TBL] [Abstract][Full Text] [Related]
17. Removal of the 20-methyl group from 2-methylene-19-nor-(20S)-1alpha,25-dihydroxyvitamin D(3) (2MD) selectively eliminates bone calcium mobilization activity.
Barycki R; Sicinski RR; Plum LA; Grzywacz P; Clagett-Dame M; Deluca HF
Bioorg Med Chem; 2009 Nov; 17(22):7658-69. PubMed ID: 19819702
[TBL] [Abstract][Full Text] [Related]
18. 22-Alkyl-20-epi-1alpha,25-dihydroxyvitamin D3 compounds of superagonistic activity: syntheses, biological activities and interaction with the receptor.
Yamamoto K; Inaba Y; Yoshimoto N; Choi M; DeLuca HF; Yamada S
J Med Chem; 2007 Mar; 50(5):932-9. PubMed ID: 17298045
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and biological properties of seco-d-ring modified 1α,25-dihydroxyvitamin D
Szybinski M; Sektas K; Sicinski RR; Plum LA; Frelek J; DeLuca HF
J Steroid Biochem Mol Biol; 2017 Jul; 171():144-154. PubMed ID: 28285018
[TBL] [Abstract][Full Text] [Related]
20. Systematic studies on synthesis, structural elucidation, and biological evaluation of A-ring diastereomers of 2-methyl-1alpha,25-dihydroxyvitamin D(3) and 20-epi-2-methyl-1alpha,25-dihydroxyvitamin D(3).
Takayama H; Konno K; Fujishima T; Maki S; Liu Z; Miura D; Chokki M; Ishizuka S; Smith C; DeLuca HF; Nakagawa K; Kurobe M; Okano T
Steroids; 2001; 66(3-5):277-85. PubMed ID: 11179735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
